-
What will be the projected value of Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by 2035?
The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market is projected to reach USD 1108.03 Million by 2035, expanding at a steady pace during the forecast period. Market growth is supported by rising demand, technological advancements, and increasing adoption across major end-use industries worldwide.
-
What is the expected CAGR of the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market during 2026-2035?
The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market is expected to grow at a CAGR of 21.65% during the forecast period from 2026 to 2035.
-
Which companies are leading the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
Key players in the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market market include SOLX (U.S.), Glaukos Corp (U.S.), iSTAR Medical (Belgium), Ivantis (U.S.), Santen Pharmaceutical Co., Ltd. (Japan), InnFocus (U.S.), SIGHT SCIENCES (U.S.)
-
How large was the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market in 2025?
The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market was valued at USD 505.94 Million in 2025, reflecting strong demand and continued adoption across major industries.